Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,100 | -8,498 | -8,349 | -32,818 | -11,609 |
| Depreciation Amortization | 494 | 513 | 776 | 894 | 2,907 |
| Accounts receivable | -616 | 49 | 201 | -307 | 361 |
| Accounts payable and accrued liabilities | -155 | 502 | 214 | -355 | -29 |
| Other Working Capital | 183 | 584 | -735 | 1,459 | 1,176 |
| Other Operating Activity | 2,077 | -368 | 724 | 27,574 | 1,640 |
| Operating Cash Flow | $-6,118 | $-7,219 | $-7,167 | $-3,553 | $-5,554 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,852 | 7,942 | -7,890 | N/A | N/A |
| PPE Investments | -36 | -90 | -218 | -1 | -155 |
| Purchase Sale Intangibles | -143 | -154 | -76 | -169 | -281 |
| Other Investing Activity | -143 | -154 | -76 | -169 | -281 |
| Investing Cash Flow | $-5,030 | $7,698 | $-8,184 | $-170 | $-436 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 621 | 2,000 |
| Debt Repayment | N/A | N/A | -35 | -108 | -129 |
| Common Stock Issued | 11,117 | 670 | 15,226 | 3,946 | N/A |
| Dividend Paid | N/A | -50 | -50 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,136 | 2,700 |
| Financing Cash Flow | $11,117 | $620 | $15,141 | $5,596 | $4,571 |
| Exchange Rate Effect | 19 | -33 | -66 | -212 | -279 |
| Beginning Cash Position | 2,719 | 1,652 | 1,929 | 268 | 1,965 |
| End Cash Position | 2,706 | 2,719 | 1,652 | 1,929 | 268 |
| Net Cash Flow | $-12 | $1,066 | $-276 | $1,661 | $-1,697 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,118 | -7,219 | -7,167 | -3,553 | -5,554 |
| Capital Expenditure | -36 | -90 | -218 | -1 | -155 |
| Free Cash Flow | -6,154 | -7,308 | -7,385 | -3,555 | -5,709 |